Reply to: "Hysterectomy versus continuing conservative management: which is better for disseminated intravascular coagulation?"; Shinya Matsuzaki, MD, PhD, Yoshikazu Nagase, MD, Masayuki Endo, MD, PhD, Tadashi Kimura, MD, PhD

doi:10.1007/s00404-021-05964-5

Comment

. 2022 Feb;305(2):539-541.

doi: 10.1007/s00404-021-05964-5. Epub 2021 Feb 5.

Reply to: "Hysterectomy versus continuing conservative management: which is better for disseminated intravascular coagulation?"; Shinya Matsuzaki, MD, PhD, Yoshikazu Nagase, MD, Masayuki Endo, MD, PhD, Tadashi Kimura, MD, PhD

C Biele¹, L Kaufner², A Nonnenmacher¹, K von Weizsäcker¹, M Z Muallem³, W Henrich¹, Thorsten Braun^{4

5}

Affiliations

¹ Department of obstetrics (or anesthesiology or genecology…), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany.
² Department of Anesthesiology and Operative Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
³ Department of Gynecology with Center for Oncological Surgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
⁴ Department of obstetrics (or anesthesiology or genecology…), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany. Thorsten.braun@charite.de.
⁵ Department of 'Experimental Obstetrics' and Study Group 'Perinatal Programming', Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. Thorsten.braun@charite.de.

PMID: 33544204
PMCID: PMC8840934
DOI: 10.1007/s00404-021-05964-5

Comment

Reply to: "Hysterectomy versus continuing conservative management: which is better for disseminated intravascular coagulation?"; Shinya Matsuzaki, MD, PhD, Yoshikazu Nagase, MD, Masayuki Endo, MD, PhD, Tadashi Kimura, MD, PhD

C Biele et al. Arch Gynecol Obstet. 2022 Feb.

. 2022 Feb;305(2):539-541.

doi: 10.1007/s00404-021-05964-5. Epub 2021 Feb 5.

Authors

C Biele¹, L Kaufner², A Nonnenmacher¹, K von Weizsäcker¹, M Z Muallem³, W Henrich¹, Thorsten Braun^{4

5}

Affiliations

¹ Department of obstetrics (or anesthesiology or genecology…), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany.
² Department of Anesthesiology and Operative Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
³ Department of Gynecology with Center for Oncological Surgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
⁴ Department of obstetrics (or anesthesiology or genecology…), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany. Thorsten.braun@charite.de.
⁵ Department of 'Experimental Obstetrics' and Study Group 'Perinatal Programming', Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. Thorsten.braun@charite.de.

PMID: 33544204
PMCID: PMC8840934
DOI: 10.1007/s00404-021-05964-5

No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they do not have any conflict of interest.

Comment on

Conservative management of abnormally invasive placenta complicated by local hyperfibrinolysis and beginning disseminated intravascular coagulation.
Biele C, Kaufner L, Schwickert A, Nonnenmacher A, von Weizsäcker K, Muallem MZ, Henrich W, Braun T. Biele C, et al. Arch Gynecol Obstet. 2021 Jan;303(1):61-68. doi: 10.1007/s00404-020-05721-0. Epub 2020 Aug 18. Arch Gynecol Obstet. 2021. PMID: 32809062 Free PMC article.
Hysterectomy versus continuing conservative management: which is better for disseminated intravascular coagulation?
Matsuzaki S, Nagase Y, Endo M, Kimura T. Matsuzaki S, et al. Arch Gynecol Obstet. 2022 Feb;305(2):537-538. doi: 10.1007/s00404-021-05961-8. Epub 2021 Jan 20. Arch Gynecol Obstet. 2022. PMID: 33471215 No abstract available.

References

1. Biele C, Kaufner L, Schwickert A, et al. Conservative management of abnormally invasive placenta complicated by local hyperfibrinolysis and beginning disseminated intravascular coagulation. Arch Gynecol Obstet. 2020 doi: 10.1007/s00404-020-05721-0. - DOI - PMC - PubMed
1. Clausen C, Lonn L, Langhoff-Roos J. Management of placenta percreta: a review of published cases. Acta Obstet Gynecol Scand. 2014;93:138–143. doi: 10.1111/aogs.12295. - DOI - PubMed
1. Collins SL, Alemdar B, Van Beekhuizen HJ, et al. Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta. Am J Obstet Gynecol. 2019;220:511–526. doi: 10.1016/j.ajog.2019.02.054. - DOI - PubMed
1. Jauniaux E, Ayres-De-Campos D, Langhoff-Roos J, et al. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2019;146:20–24. doi: 10.1002/ijgo.12761. - DOI - PubMed
1. Jauniaux E, Hussein AM, Zosmer N, et al. A new methodologic approach for clinico-pathologic correlations in invasive placenta previa accreta. Am J Obstet Gynecol. 2020;222:379 e371-379 e311. doi: 10.1016/j.ajog.2019.11.1246. - DOI - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

[1] Biele C, Kaufner L, Schwickert A, et al. Conservative management of abnormally invasive placenta complicated by local hyperfibrinolysis and beginning disseminated intravascular coagulation. Arch Gynecol Obstet. 2020 doi: 10.1007/s00404-020-05721-0. - DOI - PMC - PubMed

[2] Biele C, Kaufner L, Schwickert A, et al. Conservative management of abnormally invasive placenta complicated by local hyperfibrinolysis and beginning disseminated intravascular coagulation. Arch Gynecol Obstet. 2020 doi: 10.1007/s00404-020-05721-0. - DOI - PMC - PubMed

[3] Clausen C, Lonn L, Langhoff-Roos J. Management of placenta percreta: a review of published cases. Acta Obstet Gynecol Scand. 2014;93:138–143. doi: 10.1111/aogs.12295. - DOI - PubMed

[4] Clausen C, Lonn L, Langhoff-Roos J. Management of placenta percreta: a review of published cases. Acta Obstet Gynecol Scand. 2014;93:138–143. doi: 10.1111/aogs.12295. - DOI - PubMed

[5] Collins SL, Alemdar B, Van Beekhuizen HJ, et al. Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta. Am J Obstet Gynecol. 2019;220:511–526. doi: 10.1016/j.ajog.2019.02.054. - DOI - PubMed

[6] Collins SL, Alemdar B, Van Beekhuizen HJ, et al. Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta. Am J Obstet Gynecol. 2019;220:511–526. doi: 10.1016/j.ajog.2019.02.054. - DOI - PubMed

[7] Jauniaux E, Ayres-De-Campos D, Langhoff-Roos J, et al. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2019;146:20–24. doi: 10.1002/ijgo.12761. - DOI - PubMed

[8] Jauniaux E, Ayres-De-Campos D, Langhoff-Roos J, et al. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2019;146:20–24. doi: 10.1002/ijgo.12761. - DOI - PubMed

[9] Jauniaux E, Hussein AM, Zosmer N, et al. A new methodologic approach for clinico-pathologic correlations in invasive placenta previa accreta. Am J Obstet Gynecol. 2020;222:379 e371-379 e311. doi: 10.1016/j.ajog.2019.11.1246. - DOI - PubMed

[10] Jauniaux E, Hussein AM, Zosmer N, et al. A new methodologic approach for clinico-pathologic correlations in invasive placenta previa accreta. Am J Obstet Gynecol. 2020;222:379 e371-379 e311. doi: 10.1016/j.ajog.2019.11.1246. - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Reply to: "Hysterectomy versus continuing conservative management: which is better for disseminated intravascular coagulation?"; Shinya Matsuzaki, MD, PhD, Yoshikazu Nagase, MD, Masayuki Endo, MD, PhD, Tadashi Kimura, MD, PhD

Affiliations

Reply to: "Hysterectomy versus continuing conservative management: which is better for disseminated intravascular coagulation?"; Shinya Matsuzaki, MD, PhD, Yoshikazu Nagase, MD, Masayuki Endo, MD, PhD, Tadashi Kimura, MD, PhD

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources